Others (34) have proposed plasma caspase-generated cytokeratin-18 fragments – markers of liver cell apoptosis – as non-invasive biomarkers for NASH and fibrosis in NAFLD. This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatotic liver disease.